| 000 | 01721 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518073004.0 | ||
| 264 | 0 | _c20201118 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a1875-8908 | ||
| 024 | 7 |
_a10.3233/JAD-190836 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReimand, Juhan | |
| 245 | 0 | 0 |
_aWhy Is Amyloid-β PET Requested After Performing CSF Biomarkers? _h[electronic resource] |
| 260 |
_bJournal of Alzheimer's disease : JAD _c2020 |
||
| 300 |
_a559-569 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlzheimer Disease _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aBiomarkers _xcerebrospinal fluid |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMental Status and Dementia Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeuropsychological Tests |
| 650 | 0 | 4 |
_aPeptide Fragments _xcerebrospinal fluid |
| 650 | 0 | 4 | _aPhysicians |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_atau Proteins _xcerebrospinal fluid |
| 700 | 1 | _aGroot, Colin | |
| 700 | 1 | _aTeunissen, Charlotte E | |
| 700 | 1 | _aWindhorst, Albert D | |
| 700 | 1 | _aBoellaard, Ronald | |
| 700 | 1 | _aBarkhof, Frederik | |
| 700 | 1 | _aNazarenko, Sergei | |
| 700 | 1 | _avan der Flier, Wiesje M | |
| 700 | 1 | _avan Berckel, Bart N M | |
| 700 | 1 | _aScheltens, Philip | |
| 700 | 1 | _aOssenkoppele, Rik | |
| 700 | 1 | _aBouwman, Femke | |
| 773 | 0 |
_tJournal of Alzheimer's disease : JAD _gvol. 73 _gno. 2 _gp. 559-569 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3233/JAD-190836 _zAvailable from publisher's website |
| 999 |
_c30380937 _d30380937 |
||